Posted by Michael Wonder on 12 May 2020
Third evaluation within the FINOSE collaboration
12 May 2020 - Together with the corresponding authorities in Finland and Norway, TLV has produced a joint evaluation report for the gene therapy Zynteglo within the FINOSE collaboration.
The report was the basis for TLV's assessment of Zynteglo.
FINOSE is a collaboration between the Swedish Medicines Agency Fimea (Finland), the Swedish National Medicines Agency, NoMA (Norway) and TLV (Sweden).
